Literature DB >> 19087199

Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy.

Giuseppe Pignataro1, Antonella Scorziello, Gianfranco Di Renzo, Lucio Annunziato.   

Abstract

Because clinical trials of pharmacological neuroprotective strategies in stroke have been disappointing, attention has turned to the brain's own endogenous strategies for neuroprotection. Two endogenous mechanisms have been characterized so far, namely ischemic preconditioning and ischemic postconditioning. The neuroprotective concept of preconditioning is based on the observation that a brief, noninjurious episode of ischemia is able to protect the brain from a subsequent longer ischemic insult. Recently, a hypothesis has been offered that modified reperfusion subsequent to a prolonged ischemic episode may also confer ischemic neuroprotection, a phenomenon termed postconditioning. Many pathways have been proposed as plausible mechanisms to explain the neuroprotection offered by preconditioning and postconditioning. Unfortunately, so far, none of them has clearly identified the mechanism involved in preconditioning and postconditioning. The present article will review the main mechanisms reported to date to explain the neuroprotective effect of both ischemic preconditioning and postconditioning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19087199     DOI: 10.1111/j.1742-4658.2008.06769.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  37 in total

1.  Eradicating the mediators of neuronal death with a fine-tooth comb.

Authors:  R Suzanne Zukin
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

2.  Gene expression analysis to identify molecular correlates of pre- and post-conditioning derived neuroprotection.

Authors:  Shiv S Prasad; Marsha Russell; Margeryta Nowakowska; Andrew Williams; Carole Yauk
Journal:  J Mol Neurosci       Date:  2012-04-01       Impact factor: 3.444

3.  Is it time to retire the A.V. Hill Model?: A rebuttal to the article by Professor Roy Shephard.

Authors:  Timothy D Noakes
Journal:  Sports Med       Date:  2011-04-01       Impact factor: 11.136

4.  ASIC1a contributes to neuroprotection elicited by ischemic preconditioning and postconditioning.

Authors:  Giuseppe Pignataro; Ornella Cuomo; Elga Esposito; Rossana Sirabella; Gianfranco Di Renzo; Lucio Annunziato
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-09-10

5.  The NCX3 isoform of the Na+/Ca2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning.

Authors:  Giuseppe Pignataro; Elga Esposito; Ornella Cuomo; Rossana Sirabella; Francesca Boscia; Natascia Guida; Gianfranco Di Renzo; Lucio Annunziato
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

6.  Post-ischemic conditioning in the rat retina is dependent upon ischemia duration and is not additive with ischemic pre-conditioning.

Authors:  John C Dreixler; Afzhal R Shaikh; Michael Alexander; Brian Savoie; Steven Roth
Journal:  Exp Eye Res       Date:  2010-06-23       Impact factor: 3.467

Review 7.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

8.  Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury.

Authors:  Maria Kovalska; Libusa Kovalska; Martina Pavlikova; Maria Janickova; Katarina Mikuskova; Marian Adamkov; Peter Kaplan; Zuzana Tatarkova; Jan Lehotsky
Journal:  Neurochem Res       Date:  2012-03-20       Impact factor: 3.996

9.  Protective Effects of Spatholobi Caulis Extract on Neuronal Damage and Focal Ischemic Stroke/Reperfusion Injury.

Authors:  Hee Ra Park; Heeeun Lee; Jung-Jin Lee; Nam-Hui Yim; Min-Jung Gu; Jin Yeul Ma
Journal:  Mol Neurobiol       Date:  2017-07-13       Impact factor: 5.590

10.  The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death.

Authors:  Takahiro Miyawaki; Dimitry Ofengeim; Kyung-Min Noh; Adrianna Latuszek-Barrantes; Brian A Hemmings; Antonia Follenzi; R Suzanne Zukin
Journal:  Nat Neurosci       Date:  2009-04-06       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.